Results 171 to 180 of about 2,428 (235)

Effect of early adjunctive vasopressin initiation for septic shock patients: a target trial emulation. [PDF]

Crit Care
White KC, Costa-Pinto R, Blank S, Whebell S, Quick L, Luke S, Attokaran AG, Garrett P, Ramanan M, Tabah A, Shekar K, Laupland KB, Kumar A, McCullough J, Udy A, Eastwood G, Bellomo R, Chaba A, Queensland Critical Care Research Network (QCCRN).   +18 more
europepmc   +1 more source

Breaching the Blood-Brain Interface: Vasoactive Neurons Contact Capillary Vessels of the Brain Clock in the Suprachiasmatic Nucleus. [PDF]

eNeuro
Yao Y, Cannava I, Tazebay R, Samuels S, Silverstein E, Silver R.   +5 more
europepmc   +1 more source

Vasopressin deficiency: a hypothesized driver of both social impairment and fluid imbalance in autism spectrum disorder. [PDF]

Mol Psychiatry
Clarke L, Gesundheit N, Sherr EH, Hardan AY, Parker KJ.   +4 more
europepmc   +1 more source

Increased copeptin may reflect vasopressin-related metabolic changes after bariatric surgery. [PDF]

Obesity (Silver Spring)
Galbiati F, Becetti I, Lauze M, Aulinas A, Singhal V, Bredella MA, Lawson EA, Misra M.   +7 more
europepmc   +1 more source

The organum vasculosum of the lamina terminalis contributes to neurohumoral mechanisms of renal vascular hypertension. [PDF]

Am J Physiol Regul Integr Comp Physiol
Lauar MR, Pestana-Oliveira N, Collister JP, Vulchanova L, Evans LC, Osborn JW.   +5 more
europepmc   +1 more source

Vasopressin

Seminars in Respiratory and Critical Care Medicine, 2004
Vasopressin is a hormone that is essential for both osmotic and cardiovascular homeostasis. A deficiency of vasopressin exists in some shock states and replacement of physiological levels of vasopressin can restore vascular tone. Vasopressin is therefore emerging as a rational therapy for vasodilatory shock.
Cheryl L, Holmes, James A, Russell
openaire   +2 more sources

Vasopressin Antagonists

New England Journal of Medicine, 2015
info:eu-repo/semantics ...
Vandergheynst, Frederic, Gankam Kengne, Fabrice, Decaux, Guy   +2 more
openaire   +5 more sources

Effect of exogenous vasopressin on vasopressin release

American Journal of Physiology-Endocrinology and Metabolism, 1984
To characterize the influence of extracellular volume status on vasopressin pharmacokinetics, eleven young (aged 19-31 yr) and four old (aged 62-80 yr) subjects received bolus injections of 1 mU/kg Pitressin or synthetic arginine vasopressin following 6 days of sodium depletion (10 meq Na/day) or sodium loading (250 meq Na/day).
P A, Engel, J W, Rowe, K L, Minaker, G L, Robertson   +3 more
openaire   +2 more sources

Vasopressin and vasopressin receptors in brain edema

2020
Vasopressin is a peptide hormone produced in the hypothalamus and released from the posterior pituitary. Secretion of vasopressin is followed by activation of its receptors V1a, V1b, and V2 throughout the body. Each receptor type is responsible for a specific function of vasopressin.
Emil, Zeynalov, Susan M, Jones, J Paul, Elliott   +2 more
openaire   +2 more sources

Vasopressin antagonists

Cellular and Molecular Life Sciences, 2006
Effects of vasopressin via V1a- and V2-receptors are closely implicated in a variety of water-retaining diseases and cardiovascular diseases, including heart failure, hyponatraemia, hypertension, renal diseases, syndrome of inappropriate antidiuretic hormone secretion, cirrhosis and ocular hypertension.
Lemmens, Rosa, Kamyar, Majid-Reza
openaire   +2 more sources